NewEdge Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $816K | Sell |
9,837
-27,315
| -74% | -$2.27M | ﹤0.01% | 1404 |
|
|
2025
Q1 | $3.01M | Buy |
37,152
+1,490
| +4% | +$121K | 0.02% | 683 |
|
|
2024
Q4 | $3.21M | Buy |
35,662
+548
| +2% | +$49.4K | 0.02% | 643 |
|
|
2024
Q3 | $3.47M | Buy |
35,114
+340
| +1% | +$33.6K | 0.02% | 592 |
|
|
2024
Q2 | $3.22M | Sell |
34,774
-2,069
| -6% | -$192K | 0.02% | 580 |
|
|
2024
Q1 | $3.5M | Buy |
36,843
+2,137
| +6% | +$203K | 0.03% | 499 |
|
|
2023
Q4 | $3.1M | Sell |
34,706
-317
| -0.9% | -$28.3K | 0.03% | 500 |
|
|
2023
Q3 | $2.56M | Sell |
35,023
-1,411
| -4% | -$103K | 0.03% | 523 |
|
|
2023
Q2 | $3.03M | Buy |
36,434
+26,373
| +262% | +$2.19M | 0.03% | 452 |
|
|
2023
Q1 | $767K | Buy |
10,061
+657
| +7% | +$50.1K | 0.01% | 909 |
|
|
2022
Q4 | $454K | Buy |
9,404
+5,817
| +162% | +$281K | 0.01% | 826 |
|
|
2022
Q3 | $285K | Buy |
3,587
+15
| +0.4% | +$1.19K | ﹤0.01% | 1233 |
|
|
2022
Q2 | $265K | Buy |
+3,572
| New | +$265K | ﹤0.01% | 1262 |
|
|
2022
Q1 | – | Sell |
-2,834
| Closed | -$317K | – | 1664 |
|
|
2021
Q4 | $317K | Buy |
+2,834
| New | +$317K | ﹤0.01% | 1300 |
|